Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
36.34
-1.20 (-3.20%)
At close: May 31, 2024, 4:00 PM
36.00
-0.34 (-0.94%)
After-hours: May 31, 2024, 6:32 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.06 billion as of May 31, 2024. Its market cap has increased by 39.02% in one year.
Market Cap
2.06B
Enterprise Value
1.53B
1-Year Change
39.02%
Ranking
Category
Stock Price
$36.34
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.06B, an increase of 124.50%. That is a compound annual growth rate of 7.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 2.06B | -3.20% |
May 30, 2024 | 2.13B | -1.21% |
May 29, 2024 | 2.16B | -2.09% |
May 28, 2024 | 2.20B | 23.21% |
May 24, 2024 | 1.79B | -3.64% |
May 23, 2024 | 1.86B | -2.24% |
May 22, 2024 | 1.90B | -1.30% |
May 21, 2024 | 1.92B | 2.08% |
May 20, 2024 | 1.88B | -3.35% |
May 17, 2024 | 1.95B | -1.89% |
May 16, 2024 | 1.99B | -0.51% |
May 15, 2024 | 2.00B | 3.05% |
May 14, 2024 | 1.94B | 1.79% |
May 13, 2024 | 1.90B | 1.64% |
May 10, 2024 | 1.87B | 0.24% |
May 9, 2024 | 1.87B | 1.42% |
May 8, 2024 | 1.84B | -1.04% |
May 7, 2024 | 1.86B | -1.26% |
May 6, 2024 | 1.89B | -3.82% |
May 3, 2024 | 1.96B | -0.12% |
May 2, 2024 | 1.96B | 3.79% |
May 1, 2024 | 1.89B | 3.57% |
Apr 30, 2024 | 1.83B | -0.79% |
Apr 29, 2024 | 1.84B | 4.03% |
Apr 26, 2024 | 1.77B | -0.57% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Geron | 2.11B |
Warby Parker | 2.10B |
Vera Therapeutics | 2.09B |
Privia Health Group | 2.07B |
Amphastar Pharmaceuticals | 2.07B |
Intellia Therapeutics | 2.06B |
Amneal Pharmaceuticals | 2.06B |
Myriad Genetics | 2.06B |